News Articles

Wednesday Aug 28, 2024 - 9:00 am

Clene Inc.’s (NASDAQ: CLNN) CEO Discusses Company’s Mission, CNM-Au8(R) Trial Results, and Future Plans on BioMedWire Podcast

Clene is pioneering a very unique approach to the treatment of neurodegenerative diseases such as ALS and MS with the use of an oral nanotherapeutic that can be easily administered The company has submitted CNM-Au8 biomarker and efficacy data to the Food and Drug Administration in a Type C meeting request, seeking approval to file a new drug application using the accelerated approval pathway for…

Tuesday Aug 27, 2024 - 9:45 am

SOBRsafe Inc. (NASDAQ: SOBR) Continues to Fortify Its Financial Position and Grow in the Behavioral Health Market

Transdermal alcohol detection solutions provider SOBRsafe is implementing strategies to further strengthen its financial position During Q2 2024, the company eliminated $2.6 million in debt and improved its balance sheet with a capital infusion from the exercise of warrants SOBRsafe has increased its revenue by 44% from Q2 2023 as it continues to onboard new customers in 2024 SOBRsafe (NASDAQ: SOBR), the provider of next-generation…

Tuesday Aug 27, 2024 - 9:00 am

Torr Metals Inc. (TSX.V: TMET): Harnessing the Golden Future of Canada’s Mining Might

Torr Metals is establishing itself as a key player in Canada’s booming mining industry, a global leader in the production of over a dozen essential metals The company's emphasis on early-stage district-scale copper and gold projects underscores a significant ground floor opportunity and growth potential within the sector Building on early successes by leveraging historical data to expand known mineralization trends, Torr Metals is strategically…

Monday Aug 26, 2024 - 12:45 pm

AI Innovations at Blockchain Futurist Conference: Experts Discuss the Future of Artificial Intelligence

The Blockchain Futurist Conference, held August 13-14 in Toronto, is Canada’s largest crypto, Web3 and blockchain conference. This year’s highlights included: 10,000+ attendees 250+ speakers 300+ sponsors and partners 130+ press and media 78 events for CanadaCryptoWeek 2 hackathons Key to the event are panel discussions, which spotlight areas of interest and allow attendees to hear and meet with topic experts. These moderated discussions offer…

Monday Aug 26, 2024 - 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market

Lexaria, a global innovator in drug delivery platforms, just reported positive results from its applied research program conducted in collaboration with the National Research Council of Canada (“NRC”) The study’s objective was to examine the molecular properties of semaglutide, processed with its patented DehydraTECH(TM) technology, comparing it to Rybelsus(R), the commercially available alternative Lexaria’s DehydraTECH demonstrated that semaglutide can be efficiently released in a simulated…

Monday Aug 26, 2024 - 11:15 am

SuperCom Ltd. (NASDAQ: SPCB) Reports Q2, H1 Earnings Growth, Record Profit

Electronic monitoring solutions company SuperCom Ltd. provides a suite of products and services to justice system officials worldwide, promoting public safety through the secure tracking of individuals who require supervision SuperCom’s PureSecurity technology has the ability to serve a wide variety of tracking purposes but is specifically targeting electronic monitoring of offenders, including domestic violence cases, drug rehabilitation services, and probation orders The company recently…

Monday Aug 26, 2024 - 10:30 am

ECGI Holdings Inc. (ECGI) Following Proven Path from High-End Equestrian Market to Full-Scope Luxury Market

Many renowned luxury brands – fashion houses and watchmakers – honor their equestrian roots and the strong relationship with horses, from Rolex and Longines to Burberry, Gucci, Hermès, and Ralph Lauren The companies, which have successfully remained in operation for decades and continue to be influenced by equestrian elements, underscore the proven potential of the luxury equestrian market to build large-scale luxury players Beyond an…

Monday Aug 26, 2024 - 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Announces Encouraging Clinical Trial Results, IP Portfolio Enhancement

The company has released key corporate and business updates and Q2 2024 financial results Clinical trials for both Alzheimer’s and Parkinson’s studies yielded encouraging data for lead compound buntanetap Buntanetap in combination with GLP-1 agonist dulaglutide Trulicity(R) showed increased potential to synergistically enhance cognition The company has obtained a patent and begun manufacturing of a new crystalline form of buntanetap, with improved properties Annovis Bio…

Monday Aug 26, 2024 - 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901

A long-term preclinical study of Alzheimer's Disease (“AD”) drug candidate INM-901 included four groups: untreated disease-free, INM-901-treated disease-free, placebo-treated Alzheimer's Disease, and INM-901-treated Alzheimer's Disease at two dosing levels The results showed that INM-901-treated AD groups displayed behavior trends similar to the untreated disease-free group, with a clear dose response observed in most assessments The drug has also shown a reduction in neuroinflammation and enhancement…

Friday Aug 23, 2024 - 9:00 am

SenesTech Inc. (NASDAQ: SNES) Building Quickly Across Multiple Channels

SenesTech recently released Q2 2024 financial results and hosted a conference call, confirming 50% revenue growth in the just-ended quarter, and year-to-date growth 62% During the call, Joel Fruendt, President and CEO, discussed the company’s progress and accomplishments, including the successful efficacy trial of Evolve to support the product’s approval in certain states and international jurisdictions Fruendt also discussed the company’s commercialization plans, centered around…

Thursday Aug 22, 2024 - 9:00 am

Clene Inc.’s (NASDAQ: CLNN) CNM-Au8(R) Affects Key Biomarkers and Long-term Survival in ALS Trials

Two Phase 2 independently conducted clinical trials showed significant improvement in key biomarkers among ALS patients who were administered CNM-Au8 Biomarker and efficacy data was submitted to the Food and Drug Administration for a granted Type C meeting request, with the company targeting an accelerated approval pathway CEO Rob Etherington expressed optimism about CNM-Au8's potential as a new ALS treatment, and voiced hope that ALS…

Wednesday Aug 21, 2024 - 9:45 am

National Investment Banking Association 150th Investment Conference Comes to Ft. Lauderdale, Florida

The National Investment Banking Association (“NIBA”) invites the micro-cap and small-cap investment community to its 150th investment conference. The event will be held on September 4-5, 2024, at the Westin Fort Lauderdale Beach Resort, Ft. Lauderdale, Florida. Since 1982, The National Investment Banking Association has been a not-for-profit association for the micro-cap and small-cap investment community and has hosted 149 investment conferences featuring public and…

Wednesday Aug 21, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Reports Strong Q2 2024 Results

The company reported a 28% increase in revenue, a 6% rise in bookings, a 97% improvement in GAAP gross profit and a 444% increase in cash, for the second quarter of 2024, on a year over year basis D-Wave's CEO, Dr. Alan Baratz, summarized the company's ongoing strategic direction and provided an expansive list of achievements Highlights mentioned include a quantum AI product development roadmap…

Tuesday Aug 20, 2024 - 12:15 pm

Sprout Social Inc. (NASDAQ: SPT) Appoints New Chief Revenue Officer to Accelerate Global Growth

Sprout Social (NASDAQ: SPT), a frontrunner in cloud-based social media management software, recently made headlines with the appointment of Mike Wolff as its new Chief Revenue Officer. This strategic move is aimed at bolstering Sprout Social’s global sales, success, and partnerships organization, with a keen focus on accelerating the company’s worldwide growth and expansion. Wolff’s extensive background, notably his transformative tenure at Salesforce, underscores his…

Tuesday Aug 20, 2024 - 9:00 am

Annovis Bio Inc. (NYSE: ANVS) CEO Discusses Findings of Buntanetap Phase 2/3 Alzheimer’s Study on the Bell2Bell Podcast

Annovis Bio’s lead drug candidate buntanetap has the potential to significantly improve the quality of life for early Alzheimer’s patients In a short-term Phase 2/3 study, buntanetap has been shown to work three times better than the standard of care in the market The company plans further clinical trials to validate the efficacy and safety of buntanetap in treating both Parkinson’s and Alzheimer’s diseases Annovis…

Monday Aug 19, 2024 - 10:30 am

SenesTech Inc. (NASDAQ: SNES) Offers a Sustainable and Environmentally-Friendly Solution to the Growing Rodent Problem where Poisons and Traps Have Failed

SenesTech, a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, is offering a sustainable and proactive tool in the fight against rodent pests With New York City reporting an estimated 3 million rats as one of the top five list of the most rat-infested cities in the U.S., it paints a grim picture of the…

Monday Aug 19, 2024 - 9:45 am

Canada’s Resource Rich Future: Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) Taking Canada Beyond Oil & Gold

Canada is recognized globally as an oil and gold powerhouse, but the country is also a world leader in other metals, a trend that looks to be gaining steam With strategic acquisitions, Fathom Nickel has assembled a dominant land position in Saskatchewan’s Trans-Hudson Corridor, positioning the company to become a leading nickel provider in the sustainable energy market Data continues to show mineralization open on…

Monday Aug 19, 2024 - 9:00 am

ECGI Holdings Inc. (ECGI) to Leverage AI-Driven Technologies for ‘Extraordinary Advancements’ in Unique Retail Areas

ECGI Holdings is a diversified holding company with a unique portfolio in viticulture, hospitality, and luxury fashion The company’s subsidiary Pacific Saddlery is looking to introduce technologies that leverage AI capabilities to provide customer fit recommendations amid plans to launch a new line of ready-to-wear apparel under its Allon brand The company believes AI-powered solutions will help increase conversion rates, reduce return rates, and enhance…

Friday Aug 16, 2024 - 11:15 am

Social Media Strategies Summit for Higher Education Professionals

Connect with the leaders and social media marketing heads from leading colleges and universities at the Social Media Strategies Summit for Higher Education 2024. Attractive early bird offers are available. The tickets include access to the Higher Ed Summit on October 21–22, 2024, and the Corporate Brand Summit on October 24–25. The workshops are optional and require separate registration. The sessions explore the best social…

Friday Aug 16, 2024 - 10:37 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment

Lexaria, a global innovator in drug delivery platforms, is exploring its patented DehydraTECH(TM) technology for the oral delivery of glucagon-like peptide-1 (“GLP-1”) drugs. GLP-1 drugs have shown great promise in addressing diabetes and obesity, with nearly all the major brands administered only through injection devices. A previous human study by Lexaria evidenced improved bioavailability when semaglutide was administered orally, as compared to standard Rybelsus®. Lexaria…

Friday Aug 16, 2024 - 10:30 am

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Is ‘One to Watch’

Operator of flagship Waterberg PGM Project located in South Africa, which is home to 70% of platinum and 35% of palladium global mine production in 2023 Over $89M invested to date in exploration and feasibility engineering since initial discovery in 2011 The Waterberg Project has proven and estimated reserves of 19.5 million ounces of PGMs and gold with a projected production life of 45 years…

Friday Aug 16, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Expands Product Roadmap to Bring Power of Quantum to Artificial Intelligence & Machine Learning

Expanded product roadmap to enhance D-Wave’s Leap(TM) quantum cloud service and bring new Quantum AI solutions to market Initiative targets three key development areas: quantum distributions for generative AI, Restricted Boltzmann Machine (“RBM”) architectures, and GPU integration CEO Dr. Alan Baratz emphasizes the potential of annealing quantum computing to transform AI/ML by offering more efficient model training, reduced energy consumption, and faster time-to-solution D-Wave Quantum…

Thursday Aug 15, 2024 - 9:45 am

Nightfood Holdings Inc. (NGTF): The Power of Portfolio Diversification

Nightfood is blowing up TikTok with its sleep-friendly cookies for nighttime snackers 2024 has been a transformational year, as Nightfood Holdings diversifies into new markets, including Robots-as-a-service (“RaaS”) Nightfood has acquired Future Hospitality Ventures, providing cutting edge technologies for the hospitality and foodservice industry, and signed a Letter of Intent to acquire CarryOutSupplies.com, a packaging distribution company with sales on the rise after $2 million…

Thursday Aug 15, 2024 - 9:00 am

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) Is ‘One to Watch’

Renforth Resources Inc. is a mineral exploration company engaged in the acquisition, exploration and development of mineral properties in Canada The company holds gold and battery mineral resources in Quebec’s mining heartland Renforth Resources in July 2024 resumed exploration on its Parbec Gold Deposit, consisting of a surface soil sampling and prospecting campaign The company in July 2024 received a C$262,500 grant from the Province…

Wednesday Aug 14, 2024 - 9:45 am

Annovis Bio Inc. (NYSE: ANVS) Lead Compound Shows Synergistic Cognitive Enhancement

Annovis Bio’s lead compound, buntanetap, shows significant enhanced cognitive benefits when combined with GLP-1 agonist dulaglutide in a mouse model Buntanetap targets neurodegenerative conditions like Alzheimer’s and Parkinson’s diseases GLP-1 agonists, typically used for diabetes, weight loss, and heart conditions, have shown potential in addressing neuroinflammation and neurodegeneration The combination treatment results were compelling: While buntanetap alone restored cognitive function to 100% and dulaglutide alone…

Wednesday Aug 14, 2024 - 9:00 am

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF): A Canadian Junior Mining Company on the Hunt for Nickel Riches

The Trans-Hudson Orogeny (Corridor) stretches hundreds of kilometers across North America and includes a long history of successful mines, while remaining highly underexplored Fathom Nickel owns the commanding land position in the Rottenstone Domain region of the Trans-Hudson Corridor, with 122,000+ highly prospective hectares Fathom Nickel projects include the past-producing Rottenstone Mine, multiple high-grade deposits that remain open in all-directions, mineralization that the company continues…

Tuesday Aug 13, 2024 - 10:30 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Releases Q2, H1 Financial Results, Key Update on Argentinian Mining Project

This has been the company’s most profitable quarter in the last eight years, according to CEO Rob McEwen Revenue was up 38%, driven by an increase in gold prices and the amount of gold equivalent ounces sold Infill drilling at Los Azules copper project has been completed, confirming the geological model and the high-grade zone New Argentinian legislation designed to facilitate foreign investment is expected…

Tuesday Aug 13, 2024 - 9:45 am

Torr Metals Inc. (TSX.V: TMET): A Rising Star in the Next Big Exploration Play

Torr Metals is lighting up the map by advancing three high-potential copper and gold projects in Canada, all located in prime mining jurisdictions with increasing M&A activity by major mining companies Each of Torr's projects boasts key traits sought by majors: high-grades, prime location, robust infrastructure, full project ownership, and significant scalability The company’s assets are situated near major mining operations, including Canada’s largest open-pit…

Tuesday Aug 13, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Sees Double Digit Growth in 1H 2024 Training Enrollments with Workforce Development Initiative

The "Quantum Programming Core" course experienced a 53% rise in enrollments, while total enrollments, including both the "Core" and "Foundations for Quantum Programming" courses, increased by 85% D-Wave provides access to its Leap(TM) quantum cloud service in 42 countries, allowing learners to utilize D-Wave software and tools including the Ocean(TM) SDK Nearly 90% of learners that have completed a D-Wave training course recommend it D-Wave…

Monday Aug 12, 2024 - 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program

The company provided updates for its study programs for 2024, with a focus on its glucagon-like peptide-1 (“GLP-1”) agonist research program, targeting a significant step up in addressing worldwide diabetes and obesity, a tremendous market Lexaria has its Human Pilot Study #3 lined up, as well as its chronic dosing human study, both studies will begin dosing later this year Lexaria Bioscience (NASDAQ: LEXX), a…

Monday Aug 12, 2024 - 11:15 am

ECGI Holdings Inc. (ECGI) Makes Good Use of Luxury Equestrian Market to Additionally Grow Its Expanding Customer Base

ECGI Holdings is targeting a share of the growing luxury goods market by designing, manufacturing, and selling luxury equestrian apparel and equipment through its subsidiary Pacific Saddlery The company sees the utilization of smaller focused markets as a proven entrance pathway to much larger general luxury markets Bain & Company valued the global luxury goods market at €362 billion ($395.4 billion) in 2023 and expects…

Monday Aug 12, 2024 - 10:30 am

Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions

Clene has conducted five Phase 2 clinical trials, three with long-term extensions, and three expanded access programs (with additional studies ongoing) to evaluate the safety and efficacy of CNM-Au8 The global ALS treatment market is poised for growth, driven by an aging population and limited current treatment options CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health, and…

Monday Aug 12, 2024 - 9:45 am

Rising Domestic Violence Incidents Represents Expanding Opportunity for EM Tech Innovator SuperCom Ltd. (NASDAQ: SPCB)

Domestic violence worldwide is fostering a concerted response by criminal justice officials and legislators upset by the deadly fallout of offenders who violate court-ordered protective measures for victims Tennessee recently passed a statewide law establishing specific targets for electronic monitoring of offenders via GPS and communication with victims, creating clear and timely awareness of situations in which offenders are in proximity to victims Electronic monitoring…

Monday Aug 12, 2024 - 9:00 am

Annovis Bio Inc. (NYSE: ANVS) Secures U.S. Patent Covering Methods For Treating TBI and Preventing Nerve Cell Death With Buntanetap

U.S. Patent No. 12,042,482 specifically addresses traumatic brain injury (“TBI”) treatment with buntanetap, enhancing Annovis Bio’s portfolio that includes various patents and applications for using buntanetap in treating both acute and chronic neurodegenerative diseases and mental illnesses Buntanetap targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43 TBI is one of the major causes of death…

Friday Aug 09, 2024 - 10:30 am

Crypto Fest 2024 – Returns for its 6th Edition, Cape Town, South Africa

Join the crypto saga as Crypto Fest returns with its 6th edition, bringing together the dynamic African crypto and blockchain community in the picturesque city of Cape Town, South Africa on October 10-12th, 2024. This year Crypto Fest 2024 expands over three days with the main event on the 11 October taking place at the iconic DHL Stadium, home to the FIFA World Cup in…

Friday Aug 09, 2024 - 9:45 am

Astiva Health Inc. Focused on Establishing Lifelong Relationships, Providing Tailored Healthcare Approach to Underserved Populations

Survey indicates sizable proportion of older adult population copes with healthcare costs by skipping treatments, cutting back on basic and essential needs Astiva Health is keenly aware of problems faced by underserved senior population The company strives to bridge healthcare gaps through proactive, culturally responsive solutions As growing numbers of the U.S. population reach age 65, the challenge of adequate healthcare becomes even more critical.…

Friday Aug 09, 2024 - 9:00 am

D-Wave Quantum Inc. (NYSE: QBTS) Expands Commercial Partnership with Zapata Computing Holdings Inc. (NASDAQ: ZPTA), Hosts B.C. Dignitaries at Quantum Engineering Center of Excellence

The collaboration aims to enhance the development and deployment of integrated quantum and generative AI solutions within D-Wave's Leap™ quantum cloud platform The partnership's development efforts will target more efficient and energy-saving model training, higher-performing models, and the combined application of Generative AI and quantum optimization The commercial expansion includes a one-year enterprise subscription to Orquestra®, Zapata AI’s powerful software development and collaboration platform designed…

Thursday Aug 08, 2024 - 11:15 am

CBDC Cruise Presents Crypto Blockchain Defi Conversations – Summit on the Seas

CBDC Cruises offers a once-in-a-lifetime experience with its ‘Summit on the Seas’ to C-level executives, professionals, enthusiasts, and members of the Crypto, DeFi, and Blockchain community. Attendees can enjoy top-notch amenities and a luxury experience as the cruise sets sail from Fort Lauderdale on November 16, 2024. Be a part of first-class networking, discussions, explorations, and collaborations as executives, enthusiasts, and families, all will sail…

Thursday Aug 08, 2024 - 10:30 am

CannaCon Midwest Cleveland Convention To Focus On The Local Community

Cannabis growers, traders, license holders, physicians, patients, regulatory authorities, capital investors, professionals, and enthusiasts are invited to attend the CannaCon Cleveland Conference at the Huntington Convention Center, Cleveland, on October 3-4, 2024. The venue of the event, the Huntington Convention Center is situated in the heart of downtown Cleveland, near the legendary Rock & Roll Hall of Fame and the International Women’s Air & Space Museum,…

Thursday Aug 08, 2024 - 9:45 am

NECANN’s Michigan Cannabis Convention Offers Unique Business Ideas for Cannabis Sector

Businesses, entrepreneurs, investors, educators, patients, advocates, and consumers are invited to attend the NECANN Michigan Cannabis Convention on September 20-21, 2024, in Grand Rapids. NECANN events are organized to meet the needs and provide collaborative opportunities for the local cannabis community. One of the biggest cannabis conventions in the country, NECANN events witness some of the most eminent dignitaries of the cannabis spectrum gracing the…

Articles

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions